Chloroquine and Hydroxychloroquine in the Era of SARS – CoV2: Caution on Their Cardiac Toxicity
- 13 April 2020
- journal article
- editorial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 40 (5), 387-388
- https://doi.org/10.1002/phar.2387
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseasesJournal of Antimicrobial Chemotherapy, 2015
- The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine TherapyJAMA Ophthalmology, 2014
- QT interval prolongation and the risk of torsades de pointes: essentials for cliniciansCurrent Medical Research and Opinion, 2013
- Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized PatientsCirculation: Cardiovascular Quality and Outcomes, 2013
- Hydroxychloroquine: From Malaria to AutoimmunityClinical Reviews in Allergy & Immunology, 2011
- Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular ArrhythmiaClinical Toxicology, 2006
- Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseasesLupus, 1996
- The Hazards of Chloroquine Self Prescription in West AfricaJournal of Toxicology: Clinical Toxicology, 1995
- Clinical Pharmacokinetics of Slow-Acting Antirheumatic DrugsClinical Pharmacokinetics, 1993
- Torsade de pointes due to quinidine: Observations in 31 patientsAmerican Heart Journal, 1984